D.E. Shaw & Co’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.33M | Sell |
516,857
-32,809
| -6% | -$148K | ﹤0.01% | 1829 |
|
|
2025
Q1 | $2.44M | Sell |
549,666
-65,465
| -11% | -$290K | ﹤0.01% | 1741 |
|
|
2024
Q4 | $4.82M | Sell |
615,131
-172,405
| -22% | -$1.35M | ﹤0.01% | 1338 |
|
|
2024
Q3 | $10.4M | Sell |
787,536
-138,921
| -15% | -$1.83M | 0.01% | 938 |
|
|
2024
Q2 | $11.2M | Sell |
926,457
-141,702
| -13% | -$1.71M | 0.01% | 850 |
|
|
2024
Q1 | $17.4M | Sell |
1,068,159
-255,621
| -19% | -$4.16M | 0.01% | 648 |
|
|
2023
Q4 | $9.03M | Sell |
1,323,780
-25,430
| -2% | -$173K | 0.01% | 909 |
|
|
2023
Q3 | $7.35M | Buy |
1,349,210
+73,813
| +6% | +$402K | 0.01% | 967 |
|
|
2023
Q2 | $8.66M | Buy |
1,275,397
+484,441
| +61% | +$3.29M | 0.01% | 965 |
|
|
2023
Q1 | $3.96M | Buy |
790,956
+322,292
| +69% | +$1.61M | ﹤0.01% | 1478 |
|
|
2022
Q4 | $2.29M | Buy |
468,664
+353,174
| +306% | +$1.72M | ﹤0.01% | 1958 |
|
|
2022
Q3 | $1.67M | Buy |
115,490
+74,103
| +179% | +$1.07M | ﹤0.01% | 2227 |
|
|
2022
Q2 | $626K | Sell |
41,387
-97,270
| -70% | -$1.47M | ﹤0.01% | 2941 |
|
|
2022
Q1 | $1.65M | Buy |
+138,657
| New | +$1.65M | ﹤0.01% | 2564 |
|
|
2021
Q3 | – | Sell |
-39,083
| Closed | -$1.32M | – | 3895 |
|
|
2021
Q2 | $1.32M | Sell |
39,083
-41,382
| -51% | -$1.4M | ﹤0.01% | 2341 |
|
|
2021
Q1 | $2.43M | Buy |
80,465
+25,422
| +46% | +$769K | ﹤0.01% | 1753 |
|
|
2020
Q4 | $2.73M | Buy |
55,043
+43,303
| +369% | +$2.14M | ﹤0.01% | 1606 |
|
|
2020
Q3 | $451K | Sell |
11,740
-19,996
| -63% | -$768K | ﹤0.01% | 2151 |
|
|
2020
Q2 | $1.37M | Buy |
31,736
+11,236
| +55% | +$485K | ﹤0.01% | 1785 |
|
|
2020
Q1 | $535K | Sell |
20,500
-28,928
| -59% | -$755K | ﹤0.01% | 2122 |
|
|
2019
Q4 | $1.55M | Buy |
+49,428
| New | +$1.55M | ﹤0.01% | 1726 |
|